These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21116711)

  • 1. Hypertension, left ventricular hypertrophy and chronic kidney disease.
    Taddei S; Nami R; Bruno RM; Quatrini I; Nuti R
    Heart Fail Rev; 2011 Nov; 16(6):615-20. PubMed ID: 21116711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review.
    Cerasola G; Nardi E; Palermo A; Mulè G; Cottone S
    J Nephrol; 2011; 24(1):1-10. PubMed ID: 20437402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient.
    Schmid H; Schiffl H; Lederer SR
    Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):465-70. PubMed ID: 21738032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic cardiovascular risk factors in chronic kidney disease: what are the effects of intervention?
    McMahon LP
    Semin Dial; 2003; 16(2):128-39. PubMed ID: 12641877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
    Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
    Levin A
    Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of etiology and complications in children with stage 5 chronic kidney disease].
    Zhong C; Chen YL; Yu XX; Yang Q; Shi YQ; Tan LW; Wang AS; Wu DQ; Zhang GF; Yang HP; Li Q; Wang M
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1109-1117. PubMed ID: 38018048
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease.
    Martinez-Vea A; Marcas L; Bardají A; Romeu M; Gutierrez C; García C; Compte T; Nogues R; Peralta C; Giralt M
    Clin Nephrol; 2012 Mar; 77(3):171-81. PubMed ID: 22377247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE; Kutyrina IM; Shvetsov MIu
    Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge.
    Levin A
    Kidney Int Suppl; 2002 May; (80):35-8. PubMed ID: 11982810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
    Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
    Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival?
    Covic A; Voroneanu L; Goldsmith D
    Nephron Clin Pract; 2010; 116(3):c187-95. PubMed ID: 20606478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships of high cardiac output with ventricular morphology, myocardial energetics, and energy costs in hemodialysis patients with preserved ejection fraction.
    Harada T; Obokata M; Kurosawa K; Sorimachi H; Yoshida K; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):469-479. PubMed ID: 30328027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Masked hypertension associates with left ventricular hypertrophy in children with CKD.
    Mitsnefes M; Flynn J; Cohn S; Samuels J; Blydt-Hansen T; Saland J; Kimball T; Furth S; Warady B;
    J Am Soc Nephrol; 2010 Jan; 21(1):137-44. PubMed ID: 19917781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Endothelial and Mild Renal Dysfunction With the Severity of Left Ventricular Hypertrophy in Hypertensive Patients.
    Cao C; Hu JX; Dong YF; Zhan R; Li P; Su H; Peng Q; Wu T; Huang X; Sun WH; Wu QH; Cheng XS
    Am J Hypertens; 2016 Apr; 29(4):501-8. PubMed ID: 26232035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular remodeling and arterial remodeling in patients with chronic kidney disease stage 1-3.
    Pluta A; Stróżecki P; Krintus M; Odrowąż-Sypniewska G; Manitius J
    Ren Fail; 2015 Aug; 37(7):1105-10. PubMed ID: 26156686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.